Related Experiment Video
Updated: Dec 14, 2025
09:04
Activation and Measurement of NLRP3 Inflammasome Activity Using IL-1β in Human Monocyte-derived Dendritic Cells
Published on: May 22, 2014
21.3K
Severe COVID-19: NLRP3 Inflammasome Dysregulated
Daan F van den Berg1, Anje A Te Velde1
1Amsterdam UMC, Academic Medical Center, Tytgat Institute for Liver and Intestinal Research, Amsterdam Gastroenterology, Endocrinology and Metabolism, Amsterdam, Netherlands.
Frontiers in Immunology
|July 17, 2020
Summary
Severe COVID-19 may stem from dysregulated NLRP3 inflammasome activation, impacting immune fitness. Understanding this mechanism offers potential therapeutic targets for severe disease and cytokine storms.
Area of Science:
- Immunology
- Virology
- Pathophysiology
Background:
- SARS-CoV-2 infection can activate the NLRP3 inflammasome.
- This activation may create an endogenous adjuvant effect crucial for adaptive immunity.
- Dysregulated NLRP3 inflammasome activity is linked to severe COVID-19 outcomes.
Purpose of the Study:
- To explore the role of NLRP3 inflammasome activation in COVID-19 pathogenesis.
- To investigate how immune system fitness influences COVID-19 severity via NLRP3 inflammasome regulation.
- To propose potential treatment strategies targeting NLRP3 inflammasome dysregulation.
Main Methods:
- Conceptual analysis of SARS-CoV-2-NLRP3 inflammasome interactions.
- Review of immune system fitness in the context of COVID-19.
- Development of hypothetical scenarios for clinical application.
Main Results:
- SARS-CoV-2 may induce NLRP3 inflammasome activation, contributing to immune responses.
- Inability to downregulate NLRP3 inflammasome activation correlates with heterogeneous COVID-19 responses.
- Reduced immune fitness can lead to dysregulated NLRP3 inflammasome activity, causing severe disease, tissue damage, and cytokine storms.
Conclusions:
- NLRP3 inflammasome dysregulation is a key factor in severe COVID-19.
- Immune fitness dictates the capacity to control NLRP3 inflammasome activation.
- Targeting dysregulated NLRP3 inflammasome activity presents a therapeutic avenue for severe COVID-19.
Related Concept Videos
02:26NF-κB-dependent Signaling Pathway
9.6K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
9.6K
01:31Regulation of the Unfolded Protein Response
2.9K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.9K